文献速递心脑血管急症呼吸衰竭与机械通气

肺栓塞新预后因子:单核细胞计数与高密度脂蛋白胆固醇比值

The new prognostic factor for pulmonary embolism: The ratio of monocyte count to HDL cholesterol.
PubMed 文献 · Am J Emerg Med · 2020-07-16
一句话结论在急诊诊断的肺栓塞患者中,单核细胞/HDL胆固醇比值(MHR)≥19预测院内死亡的敏感度89.3%、特异度82.0%。

该研究回顾性纳入269例急诊诊断的肺栓塞患者,计算单核细胞计数与高密度脂蛋白胆固醇比值(MHR),并记录肺栓塞严重指数(PESI)。MHR以19为界值时预测院内死亡的敏感度为89.3%、特异度为82.0%。作者认为MHR可作为肺栓塞患者死亡率评估的强预测指标,有助于更快启动治疗。

要点

  • MHR以19为界值预测院内死亡:敏感度89.3%、特异度82.0%。
  • 研究为回顾性设计,共纳入269例急诊肺栓塞患者。
  • 作者认为MHR可作为根据血常规和生化结果判断预后的强预测指标。

适用人群与场景

  • 在急诊 clinic 诊断的肺栓塞患者,共269例,平均年龄64.51±12.4岁。

诊断标准与关键阈值

  • 诊断标准:原文未提及肺栓塞的具体诊断标准。
  • MHR计算:单核细胞计数与高密度脂蛋白胆固醇(HDL)的比值。
  • 预测界值:MHR 19为cut-off值,敏感度89.3%、特异度82.0%。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:回顾性研究;样本量269例;单中心或多中心原文未提及;人群为急诊诊断的肺栓塞患者。
  • MHR 19 cut-off值预测院内死亡:敏感度89.3%、特异度82.0%。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 证据等级或推荐强度:原文未提及。
  • 局限:原文明确写为回顾性研究(retrospectively);其余局限原文未述。

对床旁实践的改变

  • 对急诊诊断的肺栓塞患者,可计算MHR(单核细胞计数/HDL)辅助评估院内死亡风险。
  • MHR≥19时提示院内死亡风险较高(敏感度89.3%、特异度82.0%),可结合PESI等指标综合判断。
  • 原文未提及该指标对治疗决策或处置流程的具体改变。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

PURPOSE: Aim of this study is to investigate effectiveness of the monocyte to HDL cholesterol ratio in patients diagnosed with pulmonary embolism for predicting intra-hospital mortality.

METHOD: A total of 269 patients diagnosed with pulmonary embolism in the emergency clinic were included in the study. Study was conducted retrospectively. Pulmonary Embolism Severity Index (PESI), Monocyte count and high density lipoprotein cholesterol (HDL) values were determined. MHR values of the patients were calculated. SPSS 26 package program was used to investigate the effectiveness of MHR in predicting mortality.

FINDINGS: Mean age of the patients was 64.51 ± 12.4 years. PESI, Number of monocytes and MHR were significantly higher in the group with mortality than the group without mortality (p < .05). HDL values were significantly lower (p < .05) in mortality group. Sensitivity of MHR 19 cut off value was 89.3%, and its specificity was 82.0%.

CONCLUSION: Use of predictors for mortality estimation in patients diagnosed with acute pulmonary embolism is important for faster administration of treatment modalities. We think MHR values can be used as a strong predictor according to the hemogram parameters and biochemical results.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Avci A, Biricik S, Avci BS, et al. The new prognostic factor for pulmonary embolism: The ratio of monocyte count to HDL cholesterol. Am J Emerg Med. 2020. PMID: 33071082. doi:10.1016/j.ajem.2020.07.026

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。